QA: Kura Oncology Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001422143_2022_Kura_Oncology_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001422143, Kura Oncology Inc

  xvar xval
0 AssetsCurrent 522,289,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,673,000
3 remainder_Assets 9,089,000
4 LiabilitiesCurrent 22,455,000
5 LiabilitiesNoncurrent 4,987,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 84,508,223
9 ResearchAndDevelopmentExpense 98,961,465
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 556,078
13 remainder_ComprehensiveNetIncome -5,728,051
  yvar yval
0 Assets 534,051,000
1 Liabilities 27,442,000
2 Expenses 183,469,688
3 Revenues 0
4 StockholdersEquity 506,609,000
5 NetIncome -182,913,610
6 ComprehensiveNetIncome -185,777,636
7 BaseVar 375,623,408
8 EconomicCapitalRatiobeforeLimitedLiability 3.27
9 EconomicCapitalRatio 3.87

Edgar->Model Mapping

Feature Distribution

Change over Time